EcoDrugPlus

Ensembl ID : ENSFHEG00000023213
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSFHEG00000023239
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSFHEG00000011443
Gene Symbol: -
Cross references: -
237 Possible Orthologues:

Ensembl ID : ENSFHEG00000022756
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSFHEG00000010086
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSFHEG00000005045
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSFHEG00000008951
Gene Symbol: -
Cross references: -
230 Possible Orthologues:

Ensembl ID : ENSFHEG00000010577
Gene Symbol: -
Cross references: -
142 Possible Orthologues:

Ensembl ID : ENSFHEG00000011500
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSFHEG00000010644
Gene Symbol: -
Cross references: -
255 Possible Orthologues:

Ensembl ID : ENSFHEG00000012626
Gene Symbol: -
Cross references: -
389 Possible Orthologues:

Ensembl ID : ENSFHEG00000011743
Gene Symbol: -
Cross references: -
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).